Literature DB >> 34206853

Comparison of the Intestinal Microbiome of Italian Patients with Multiple Sclerosis and Their Household Relatives.

Paola Galluzzo1,2, Fanny Claire Capri1, Luca Vecchioni1, Sabrina Realmuto3, Luca Scalisi4, Salvatore Cottone5, Domenico Nuzzo6, Rosa Alduina1.   

Abstract

Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system, caused by a combination of genetic and environmental factors. In recent years, a role in MS pathogenesis was assigned to the gut microbiota. However, different signatures of gut dysbiosis have been shown to depend on environmental factors, like diet and lifestyle. In this study, we compared the gut microbiome in MS patients and their household healthy relatives sharing lifestyle and environmental factors. Faecal metagenomic DNA was extracted and the V3-V4 regions of the conserved bacterial 16S ribosomal RNA gene were amplified and sequenced. While overall bacterial communities were similar, specific families differed between healthy and MS subjects. We observed an increase in Ruminococcaceae, Christensenellaceae, Desulfovibrionaceae, Clostridiales, and Family XIII in MS patients, while Bacteroidaceae, Tannerellaceae, Veillonellaceae, and Burkholderiaceae were more abundant in healthy controls. In addition, principle coordinate analysis showed that the gut microbiome of all MS patients formed a cluster being less diverse than the household relatives and that gut microbiota of MS patients with EDSS 4.5-7 formed a distinct cluster in respect to their controls. Overall, our study is consistent with the hypothesis that MS patients have gut microbial dysbiosis and evidenced the importance of environmental factors in shaping the gut microbiome.

Entities:  

Keywords:  Bacteroidaceae; Burkholderiaceae; Clostridiales; Desulfovibrionaceae Christensenellaceae; Ruminococcaceae; Tannerellaceae; Veillonellaceae; microbiome; multiple sclerosis

Year:  2021        PMID: 34206853     DOI: 10.3390/life11070620

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  40 in total

1.  Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.

Authors:  Kenichiro Takahashi; Atsushi Nishida; Takehide Fujimoto; Makoto Fujii; Makoto Shioya; Hirotsugu Imaeda; Osamu Inatomi; Shigeki Bamba; Mitsushige Sugimoto; Akira Andoh
Journal:  Digestion       Date:  2016-01-14       Impact factor: 3.216

2.  Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.

Authors:  Erin M Hill-Burns; Justine W Debelius; James T Morton; William T Wissemann; Matthew R Lewis; Zachary D Wallen; Shyamal D Peddada; Stewart A Factor; Eric Molho; Cyrus P Zabetian; Rob Knight; Haydeh Payami
Journal:  Mov Disord       Date:  2017-02-14       Impact factor: 10.338

3.  Gut microbiota in early pediatric multiple sclerosis: a case-control study.

Authors:  Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Feng Zhu; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal:  Eur J Neurol       Date:  2016-05-13       Impact factor: 6.089

Review 4.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

5.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.

Authors:  Julien Loubinoux; Jean-Pierre Bronowicki; Ines A C Pereira; Jean-Louis Mougenel; Alain E Faou
Journal:  FEMS Microbiol Ecol       Date:  2002-05-01       Impact factor: 4.194

6.  METAGENassist: a comprehensive web server for comparative metagenomics.

Authors:  David Arndt; Jianguo Xia; Yifeng Liu; You Zhou; An Chi Guo; Joseph A Cruz; Igor Sinelnikov; Karen Budwill; Camilla L Nesbø; David S Wishart
Journal:  Nucleic Acids Res       Date:  2012-05-29       Impact factor: 16.971

7.  Alterations of the human gut microbiome in multiple sclerosis.

Authors:  Sushrut Jangi; Roopali Gandhi; Laura M Cox; Ning Li; Felipe von Glehn; Raymond Yan; Bonny Patel; Maria Antonietta Mazzola; Shirong Liu; Bonnie L Glanz; Sandra Cook; Stephanie Tankou; Fiona Stuart; Kirsy Melo; Parham Nejad; Kathleen Smith; Begüm D Topçuolu; James Holden; Pia Kivisäkk; Tanuja Chitnis; Philip L De Jager; Francisco J Quintana; Georg K Gerber; Lynn Bry; Howard L Weiner
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

8.  Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.

Authors:  Tatjana Reynders; Lindsay Devolder; Mireia Valles-Colomer; Ann Van Remoortel; Marie Joossens; Jacques De Keyser; Guy Nagels; Marie D'hooghe; Jeroen Raes
Journal:  Ann Clin Transl Neurol       Date:  2020-03-12       Impact factor: 4.511

9.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

10.  Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Authors:  Jun Chen; Nicholas Chia; Krishna R Kalari; Janet Z Yao; Martina Novotna; M Mateo Paz Soldan; David H Luckey; Eric V Marietta; Patricio R Jeraldo; Xianfeng Chen; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci; Heidi Nelson; Joseph A Murray; Ashutosh K Mangalam
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more
  3 in total

Review 1.  Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.

Authors:  Enrique González-Madrid; Ma Andreina Rangel-Ramírez; María José Mendoza-León; Oscar Álvarez-Mardones; Pablo A González; Alexis M Kalergis; Ma Cecilia Opazo; Claudia A Riedel
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

2.  Bacterial variation in the oral microbiota in multiple sclerosis patients.

Authors:  Zahra Zangeneh; Ahya Abdi-Ali; Kianoosh Khamooshian; Amirhoushang Alvandi; Ramin Abiri
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

3.  A systematic review on omics data (metagenomics, metatranscriptomics, and metabolomics) in the role of microbiome in gallbladder disease.

Authors:  Paola Di Carlo; Nicola Serra; Rosa Alduina; Riccardo Guarino; Antonio Craxì; Anna Giammanco; Teresa Fasciana; Antonio Cascio; Consolato M Sergi
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.